Zeng Lingbing 曾令冰
Companies 任职公司
| Company 公司 | Industry 行业 | Role 职务 | Since 起始 | Grade 评级 |
|---|---|---|---|---|
| Walvax Biotechnology 沃森生物 | Biologics | Independent Director | 27 Jan 2026 | D |
| Chengdu Kanghua Biological Products 康华生物 | Biologics | Independent Director | 25 Nov 2025 | B |
Biography 简历
曾令冰,男,出生于1957年,中国国籍,无境外永久居留权,中共党员,医学研究员,硕士研究生学历,硕士研究生导师。曾任武汉生物制品研究所总经理,北京天坛生物制品股份有限公司(600161)董事、总经理,成都蓉生药业有限责任公司董事长,长春祈健生物制品有限责任公司董事长;历任中国药典委员会委员、国家食品药品监督管理局新药审评委员等职务。现任云南沃森生物技术股份有限公司(300142)独立董事、康华生物独立董事。
English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Zeng Lingbing, male, born in 1957, Chinese nationality, no overseas permanent residence, member of the Communist Party of China, medical researcher, master's degree, master's thesis supervisor. Former General Manager of 武汉生物制品研究所, Director and General Manager of 北京天坛生物制品股份有限公司 (Beijing Tiantan Biological Products) (600161), Chairman of 成都蓉生药业有限责任公司, Chairman of 长春祈健生物制品有限责任公司, Has held positions such as member of the Chinese Pharmacopoeia Commission, member of the New Drug Review Committee of 国家食品药品监督管理局. Currently Independent Director of 云南沃森生物技术股份有限公司 (Walvax Biotechnology) (300142), Independent Director of 康华生物 (Chengdu Kanghua Biological Products).